Essity AB (publ) (LON:0RQC)
United Kingdom · Delayed Price · Currency is GBP · Price in SEK | Market Cap | 14.86B +2.0% |
| Revenue (ttm) | 10.49B -1.8% |
| Net Income | 839.22M -9.7% |
| EPS | 1.24 -8.2% |
| Shares Out | n/a |
| PE Ratio | 17.66 |
| Forward PE | 14.72 |
| Dividend | 0.70 (3.20%) |
| Ex-Dividend Date | Mar 27, 2026 |
| Volume | 61 |
| Open | 288.50 |
| Previous Close | 281.00 |
| Day's Range | 288.50 - 288.50 |
| 52-Week Range | 244.00 - 288.50 |
| Beta | 0.41 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 22, 2026 |
About Essity AB
Essity AB (publ) develops, produces, and sells hygiene and health products and services in Europe, North and Latin America, Asia, and internationally. The company operates through three segments: Health & Medical, Consumer Goods, and Professional Hygiene. The Health & Medical segment offers incontinence products, wound care, compression therapy, orthopedics, skincare products, and digital solutions with sensor technology under the TENA, Leukoplast, JOBST, Actimove, Cutimed, Delta-Cast, AquaCast Liner, and Hydrofera brands to family carers, prof... [Read more]
Financial Performance
In 2025, Essity AB's revenue was 138.49 billion, a decrease of -4.85% compared to the previous year's 145.55 billion. Earnings were 12.66 billion, a decrease of -39.41%.
Financial numbers in SEK Financial StatementsNews
Essity AB Earnings Call Transcript: Q3 2026
Net sales grew 4.1% YoY, with stable volumes and strong cash flow, but higher COGS compressed margins. Pricing, savings and portfolio shifts remain priorities as costs are expected to rise further in Q4.
Essity AB Quarterly report: Q3 2026
Essity AB has published its Q3 2026 quarterly earnings report on October 22, 2026.
Essity AB Slides: Q3 2026
Essity AB has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on October 22, 2026.
Essity: Interim Report Quarter 3, 2026
STOCKHOLM, Oct. 22, 2026 /PRNewswire/ -- Stable volumes, resilient profitability and strong cash flow Quarter 3, 2026 Net sales increased 4.1% to SEK 36,060m (34,638) Organic sales growth amounted to ...
Essity Earnings Decline In Q3
(RTTNews) - Essity AB (ESSITY-B.ST, ESWB.F), a hygiene and health company, on Thursday reported a decline in net income in the third quarter compared with the previous year.
Essity price target lowered to SEK 247 from SEK 251 at Jefferies
Jefferies analyst David Hayes lowered the firm’s price target on Essity (ETTYF) to SEK 247 from SEK 251 and keeps a Hold rating on the shares after updating the firm’s…
Essity upgraded to Buy from Hold at Kepler Cheuvreux
Kepler Cheuvreux analyst Karel Zoete upgraded Essity (ETTYF) to Buy from Hold with a SEK 320 price target
Essity downgraded to Sell from Buy at UBS
UBS double downgraded Essity (ETTYF) to Sell from Buy with a price target of SEK 235, down from SEK 280. The firm sees downside share risk as Essity “enters a…
Essity price target raised to SEK 240 from SEK 230 at Deutsche Bank
Deutsche Bank analyst Tom Sykes raised the firm’s price target on Essity (ETTYF) to SEK 240 from SEK 230 and keeps a Sell rating on the shares. Published first on…
Essity AB Slides: SEB Nordic Large Cap Seminar presentation
Essity AB has posted slides in relation to its latest quarterly earnings report, which was published on August 18, 2026.
Essity price target lowered to SEK 251 from SEK 263 at Jefferies
Jefferies lowered the firm’s price target on Essity (ETTYF) to SEK 251 from SEK 263 and keeps a Hold rating on the shares. The firm updated the company’s model post…
Essity downgraded to Sell from Neutral at Goldman Sachs
Goldman Sachs downgraded Essity (ETTYF) to Sell from Neutral with a SEK 255 price target The firm sees downside risk to consensus estimates, saying the company’s pricing continues to lag…
Essity AB Earnings Call Transcript: Q2 2026
Q2 2026 saw positive organic sales growth, strong volumes in most segments, and resilient margins despite cost inflation. Price increases and cost-saving programs are underway to offset higher COGS, with further margin improvement expected as integration and innovation continue.
Essity AB Quarterly report: Q2 2026
Essity AB has published its Q2 2026 quarterly earnings report on July 16, 2026.
Essity AB Slides: Q2 2026
Essity AB has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 16, 2026.
Essity AB Transcript: 23rd annual dbAccess Global Consumer Conference
Leadership is accelerating strategy execution with a decentralized structure, portfolio review, and cost-saving initiatives. Business units focus on high-value segments, innovation, and resilience, with price increases and reinvestment in growth to navigate current market challenges.
Essity AB Transcript: CMD 2026
A strategic review of the Consumer Tissue business is underway, with a focus on shifting the portfolio toward higher value-added segments and accelerating profitable growth. Clear financial targets and cost-saving initiatives support increased investment in innovation, digitalization, and sustainability, while each business area pursues tailored growth strategies.
Essity AB Press release: FY 2026
Essity AB issued a press release on May 7, 2026, disclosing material business information to investors.
Essity AB Slides: FY 2026
Essity AB has posted slides in relation to its FY 2026 quarterly earnings report, which was published on May 7, 2026.
Essity AB Earnings Call Transcript: Q1 2026
Organic sales and volume growth, improved margins, and strong cash flow marked Q1 2026, supported by a major North American acquisition and a SEK 3 billion share buyback. Input cost inflation and selective price increases are expected to shape results in H2.
Essity AB Quarterly report: Q1 2026
Essity AB has published its Q1 2026 quarterly earnings report on April 23, 2026.
Essity AB Slides: Q1 2026
Essity AB has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 23, 2026.
Essity downgraded to Underweight from Neutral at JPMorgan
JPMorgan downgraded Essity (ETTYF) to Underweight from Neutral with a price target of SEK 215, down from SEK 245. The firm says the company is facing pressure from higher pulp…
Essity price target lowered to SEK 290 from SEK 315 at UBS
UBS analyst Charles Eden lowered the firm’s price target on Essity (ETTYF) to SEK 290 from SEK 315 and keeps a Buy rating on the shares.
Essity AB Slides: FY 2026
Essity AB has posted slides in relation to its FY 2026 quarterly earnings report, which was published on March 26, 2026.